Chronic hemolysis after st. jude medical valve replacement.
نویسندگان
چکیده
منابع مشابه
Combined warfarin and antiplatelet therapy after St. Jude Medical valve replacement for mitral valve disease.
OBJECTIVES The clinical effect of combined warfarin and antiplatelet therapy on the incidence of stroke and postoperative complications after mitral (plus aortic) valve replacement was studied and compared with that observed with warfarin therapy alone. BACKGROUND It has been reported that combined warfarin and antiplatelet therapy may be effective but may be associated with an increased hemo...
متن کاملLong-term outcomes after St. Jude Medical mechanical valve implantation.
patient-year), major bleeding events (1.0%/patient-year), and aortic valve reoperation (0.26%/patient-year). They also reported that valve-related death was the most common cause of death (26.8%) and that the rates of freedom from valve-related death were 96.2%, 92.7%, 88.8%, and 86.6% at 5, 10, 15, and 20 years, respectively. These results compare favorably with the findings of previous report...
متن کاملSevere haemolytic anaemia after replacement of the mitral valve by a St Jude medical prosthesis.
Severe haemolytic anaemia developed in a 33 year old patient after the mitral valve was replaced with a St Jude medical prosthesis. This was the patient's third thoracotomy. She had already had a mitral commissurotomy and a mitral valve bioprosthesis. The patient had an E+ antibody to red blood cells as well as a paraprosthetic leak. The haemolysis became less severe once the population of E+ r...
متن کاملThe St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement.
BACKGROUND From October 1977 to October 2002, 4,480 patients (age range, 17 to 94 years; average, 64 +/- 13 years) underwent single valve replacement with the St. Jude Medical heart valve. Of 2,982 aortic (AVR) and 1,498 mitral valve replacements (MVR), concomitant coronary artery bypass grafting was performed on 42% and 33%, respectively. METHODS Cardiac Surgical Associates has maintained an...
متن کاملTranscatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience.
OBJECTIVES The purpose of this study was to demonstrate the feasibility and procedural outcomes with a new self-expanding and repositionable transcatheter heart valve. BACKGROUND Transcatheter aortic valve replacement is a viable option for selected patients with severe symptomatic aortic stenosis. However, suboptimal prosthesis positioning may contribute to paravalvular regurgitation, atriov...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Japanese Journal of Cardiovascular Surgery
سال: 1990
ISSN: 1883-4108,0285-1474
DOI: 10.4326/jjcvs.19.1273